PCM
SGHT icon

Prelude Capital Management’s Sight Sciences SGHT Stock Holding History

Prelude Capital Management’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,355
Closed -$53.4K – 1504
2023
Q4 		$53.4K Sell
10,355
-6,200
-37% -$19.1K ﹤0.01% 1071
2023
Q3 		$55.8K Buy
+16,555
New +$109K ﹤0.01% 1039

Other funds holding SGHT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Prelude Capital Management's SGHT Position: Q1 2024 in Review

Prelude Capital Management sold out of Sight Sciences (SGHT) in Q1 2024, closing a stake of 10,355 shares — an estimated $53.4K sold.

Prelude Capital Management first reported a position in SGHT in Q3 2023 and held it in 2 quarters. The position peaked at $55.8K in Q3 2023. 65 funds tracked by Wall St. Rank hold SGHT as of Q1 2024.

  • Prelude Capital Management reported no remaining Sight Sciences position as of Q1 2024 after selling out during the quarter.
  • Prelude Capital Management sold 10,355 Sight Sciences shares in Q1 2024, an estimated $53.4K.
  • Prelude Capital Management first reported a position in Sight Sciences in Q3 2023 and held it in 2 quarters.
  • Prelude Capital Management's Sight Sciences position peaked at $55.8K in Q3 2023.
  • 65 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2024.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.